Ranbaxy gets USFDA approval for cyclobenzaprine

One of the India's largest pharma company has received US Food Drug and Administration approval for marketing its muscle relaxing drug cyclobenzaprine in US.

Ranbaxy will launch cyclobenzaprine hydrochloride in 5mg, 7.5 mg and 10 mg strength.